Growth Of Bioethics

Brian Everill (The Scientist, April 1, 1996, page 13) errs twice in his reply to my letter of Feb. 5, 1996 [page 13] on cooperation between scientists and bioethicists. First, by extracting a clause and a phrase from my letter, then combining them in inverse order, he creates a pseudoquotation. What I actually wrote was " . . . just as bioethicists must learn the scientific facts about a subject before venturing ethical pronouncements on that subject, scientists ought to learn something about e

Written byArthur Galston
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Brian Everill (The Scientist, April 1, 1996, page 13) errs twice in his reply to my letter of Feb. 5, 1996 [page 13] on cooperation between scientists and bioethicists. First, by extracting a clause and a phrase from my letter, then combining them in inverse order, he creates a pseudoquotation. What I actually wrote was " . . . just as bioethicists must learn the scientific facts about a subject before venturing ethical pronouncements on that subject, scientists ought to learn something about ethical theories and their possible use in the resolution of ethical dilemmas." I see no reason to change that statement.

Everill then suggests that anyone interested in biology attend biology courses and those interested in theories of ethics seek out a philosophy department. That's fine as far as it goes, but do we stop there? Is there to be no interdisciplinary training and thought? Should biologists abjure ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies